Rothwell Investment Advisors, LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$27.5K	Buy	+36	New	+$27.2K	0.01%	553

Other funds holding REGN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Rothwell Investment Advisors, LLC's REGN Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 36 shares worth $27.5K. The stake represents 0.01% of the portfolio and ranks #553 among its holdings.

755 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

Rothwell Investment Advisors, LLC held 36 shares of Regeneron Pharmaceuticals worth $27.5K as of Q3 2026.
Regeneron Pharmaceuticals was a new Rothwell Investment Advisors, LLC position in Q3 2026.
Regeneron Pharmaceuticals made up 0.01% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #553 holding.
755 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.